Hilbert's consistency demonstrations in FG are all demonstrations of relative consistency, which is to say that in each case the consistency of a set AX of geometric axioms is reduced to that of a familiar background theory B, demonstrating that AX is consistent if B is.
In humans, this relationship is further reinforced by the demonstration of the relative fewer proportion of Bacteroidetes in obese people by comparison with lean people and the shift toward higher relative abundance of Bacteroidetes and decreased number of Firmicutes in obese patients losing weight through low-calorie diets [ 9].
Our development also systematically explicates the tradeoffs among the spectrum of possible generalizations for POPI plans, and provides an empirical demonstration of the relative utility of EBG in partial ordering, as opposed to total ordering, planning frameworks.
"For example, we have as yet no convincing demonstration of the relative effects of pesticides on bee colonies compared to the effects of parasites, pathogens and foraging resources," she wrote.
In terms of lead optimization for in vitro potency, which is an important step in drug development, the present work offers another demonstration of the relative efficiency of using computer simulations instead of the brute force approach for lead optimization.
Evidence of an enduring multigenerational pattern of BMI may provide a clearer demonstration of the relative influence of maternal and paternal contributions to offspring BMI.
As noted above, demonstration of a relative effective increase of 37.5% in the ongoing pregnancy rates through a more accurate choice of fresh transferred embryos requires prospective randomized studies that use daily FF G-CSF bead-based immunoassay quantification.
Importantly, the combined data have enabled the demonstration of increased relative risk associated with bed sharing when the baby is breastfed and neither parent smokes and no other risk factors are present (see figure 2 and table 2).
Regulators have been demanding demonstrations of the relative efficacy of new antibiotics versus those already registered within tighter statistical parameters, i.e., shifting from "non-inferiority" to "superiority" trials [ 40, 100].
